Kezar Life Sciences buy BiotechBee
Start price
07.09.22
/
80%
€9.70
Target price
31.12.24
€20.00
Performance (%)
-76.29%
End price
05.05.23
€2.30
Summary
This prediction ended on 05.05.23 with a price of €2.30. Massive losses of -76.29% were the result for the BUY prediction by BiotechBee. BiotechBee has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Kezar Life Sciences | -0.840% | -0.840% | -71.905% |
iShares Core DAX® | 0.238% | -2.265% | 13.679% |
iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% |
iShares Nikkei 225® | 2.271% | 1.577% | 9.436% |
iShares S&P 500 | -0.296% | 4.447% | 28.577% |
According to BiotechBee what are the pros and cons of Kezar Life Sciences for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kezar Life Sciences diskutieren
Buy mit Kursziel 20,0
In the thread Trading Kezar Life Sciences
Buy beendet